Cytophagic histiocytic panniculitis: Difference between revisions

Content deleted Content added

Inline

Revision as of 22:05, 9 March 2009

Template:Wikify is deprecated. Please use a more specific cleanup template as listed in the documentation.

Cytophagic Histiocytic Panniculitis (CHP) was first described in 1980 by Winkelmann as a chronic histiocytic disease of the subcutaneous adipose tissue, which is characterized clinically by tender erythematous nodules, recurrent high fever, malaise, jaundice, organomegaly, serosal effusions, pancytopenia, hepatic dysfunction and coagulatory abnormalities.^[1] CHP may occur either isolated or as part of cutaneous manifestations of Hemophagocytic Syndrome (HPS). [2] CHP is a rare and often fatal form of panniculitis with multisystem involvement. But it can also present in a benign form involving only the subcutaneous tissue, thus having a broad clinical spectrum.

References

Smith K J, Skeleton H J, Yeagre J, Angritt P, Wagner K, James W. D., Giblin W. J., Lupton G. P. Cutaneous histopathological, immunohistochemical, and clinical manifestations inpatients with hemophagocytic syndrome. Military Medical Consortium for Applied Retroviral Research (MMCARR). Arch Dermatol 1992; 128: 193-200

References

^ Winkelmann RK, Bowie EJ. Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Intern Med.1980; 140: 1460-3

This medical article is a stub. You can help Wikipedia by expanding it.

[1] Winkelmann RK, Bowie EJ. Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Intern Med.1980; 140: 1460-3

[1]

@@ Line 1: / Line 1: @@
 {{Wikify|date=March 2009}}
-'''Cytophagic Histiocytic Panniculitis''' ('''CHP''') was first described in 1980 by Winkelmann as a chronic [[histiocytic]] disease of the [[subcutaneous]] [[adipose tissue]], which is characterized clinically by tender [[erythematous]] [[nodules]], recurrent high [[fever]], [[malaise]], [[jaundice]], [[organomegaly]], [[serosal]] effusions, [[pancytopenia]], [[hepatic]] dysfunction and [[coagulatory]] abnormalities. [1] CHP may occur either  isolated or as part of cutaneous manifestations of [[Hemophagocytic Syndrome]] (HPS). [2] CHP is a rare and often fatal form of [[panniculitis]] with multisystem involvement. But it can also present in a benign form involving only the subcutaneous tissue, thus having a broad clinical spectrum.
+'''Cytophagic Histiocytic Panniculitis''' ('''CHP''') was first described in 1980 by Winkelmann as a chronic [[histiocytic]] disease of the [[subcutaneous]] [[adipose tissue]], which is characterized clinically by tender [[erythematous]] [[nodules]], recurrent high [[fever]], [[malaise]], [[jaundice]], [[organomegaly]], [[serosal]] effusions, [[pancytopenia]], [[hepatic]] dysfunction and [[coagulatory]] abnormalities.<ref>Winkelmann RK, Bowie EJ. Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Intern Med.1980; 140: 1460-3</ref> CHP may occur either  isolated or as part of cutaneous manifestations of [[Hemophagocytic Syndrome]] (HPS). [2] CHP is a rare and often fatal form of [[panniculitis]] with multisystem involvement. But it can also present in a benign form involving only the subcutaneous tissue, thus having a broad clinical spectrum.
 ==References==
-# Winkelmann RK, Bowie EJ. Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Intern Med.1980; 140: 1460-3
 # Smith K J, Skeleton H J, Yeagre J, Angritt P, Wagner K, James W. D., Giblin W. J., Lupton G. P. Cutaneous histopathological, immunohistochemical, and clinical manifestations inpatients with hemophagocytic syndrome. Military Medical Consortium for Applied Retroviral Research (MMCARR). Arch Dermatol 1992; 128: 193-200
+== References ==
+{{Reflist}}
 {{medical-stub}}